Copyright
©2013 Baishideng Publishing Group Co.
World J Gastrointest Surg. Jun 27, 2013; 5(6): 167-172
Published online Jun 27, 2013. doi: 10.4240/wjgs.v5.i6.167
Published online Jun 27, 2013. doi: 10.4240/wjgs.v5.i6.167
Risk factor | Risk | Proposed mechanism | Notes |
Age (> 70 yr[10]) | CDI and Severe CDAD | Diminished efficacy of immune response with aging[7] | |
Medical comorbidities[7]: multiple or those involving major organ systems | CDI and Severe CDAD | Diminished efficacy of immune response | Studies are conflicting with regards to which comorbid illnesses are specifically associated The evidence supporting the association with multiple/prolonged antibiotic use is controversial as this often occurs in patients with recurrent or refractory disease who are already at risk of unfavorable outcomes |
Broad spectrum antibiotics Use of 3-4 antibiotics concurrently or prolonged (> 4 wk) use[12] | CDI | Alteration of normal colonic floral barrier to C. difficile colonization | |
Severe CDAD | |||
Suppression of gastric acid production, particularly by proton pump inhibitors[6,7] | CDI | Increased survival of the acid-labile vegetative form of C. difficile while passing through the stomach[6,7] | |
Immunosuppression[6,13] | CDI and severe CDAD | Disruption of host ability to mount an effective response to both infection and toxemia |
-
Citation: Klobuka AJ, Markelov A. Current status of surgical treatment for fulminant
clostridium difficile colitis. World J Gastrointest Surg 2013; 5(6): 167-172 - URL: https://www.wjgnet.com/1948-9366/full/v5/i6/167.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v5.i6.167